Immunocore Holdings plc (IMCR) SEC Filings https://www.immunocore.com/investors/financials-filings/sec-filings/rss Immunocore Holdings plc (IMCR) - SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_b541aae032f58bf8fdbdeabb137fc49f/immunocore/files/theme/images/logo-sm.png Immunocore Holdings plc Logo /investors Equisolve Investor Relations Suite <![CDATA[ARS - Annual Report to Security Holders]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-015125/0001140361-26-015125.pdf Thu, 16 Apr 26 16:07:10 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-015125/0001140361-26-015125.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-015122/0001140361-26-015122.pdf Thu, 16 Apr 26 16:06:27 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-015122/0001140361-26-015122.pdf <![CDATA[144 - Report of proposed sale of securities]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000149/0001974494-26-000149.pdf Wed, 08 Apr 26 15:58:24 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000149/0001974494-26-000149.pdf <![CDATA[144 - Report of proposed sale of securities]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000121/0001974494-26-000121.pdf Wed, 11 Mar 26 13:48:00 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000121/0001974494-26-000121.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001897612-26-000309/0001897612-26-000309.pdf Tue, 14 Apr 26 14:27:35 -0400 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001897612-26-000309/0001897612-26-000309.pdf <![CDATA[8-K - Current report]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-006721/0001140361-26-006721.pdf Wed, 25 Feb 26 07:31:00 -0500 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-006721/0001140361-26-006721.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000005/0001671927-26-000005.pdf Wed, 25 Feb 26 07:02:00 -0500 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000005/0001671927-26-000005.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969524-26-000002/0001969524-26-000002.pdf Thu, 19 Feb 26 17:00:56 -0500 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969524-26-000002/0001969524-26-000002.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969525-26-000002/0001969525-26-000002.pdf Thu, 19 Feb 26 17:00:52 -0500 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969525-26-000002/0001969525-26-000002.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001779466-26-000002/0001779466-26-000002.pdf Thu, 19 Feb 26 17:00:48 -0500 https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001779466-26-000002/0001779466-26-000002.pdf